Neurological Biomarker Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Neurological Biomarker Market to 2027 - Global Analysis and Forecasts by Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Others); Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, Others); End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations) and Geography

Report Code: TIPRE00003515 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Biomarkers are the molecules that indicates about the presence of a disease. The biomarkers of the neurological diseases were not that accessible in earlier days, however the advancements in the technology has enabled to track the health condition of the brain by measuring the biomarkers. This helps in the earlier detection of a disease, less invasive diagnostics and enables faster drug development and is expected to be the effective treatment.

MARKET DYNAMICS
The market for neurological biomarkers is anticipated to grow in the coming years. The driving factors that are responsible for the growth of the market are rise in the geriatric population, growing genetic disorders, rising advancement in the field of biotechnology and others. The genome editing technologies are likely to create growth opportunities for the growth of the market during the forecast period.

MARKET SCOPE
The "Global Neurological Biomarker Market Analysis to 2027" is a specialized and in-depth study of the biotechnology with a special focus on the global market trend analysis. The report aims to provide an overview of neurological biomarker market with detailed market segmentation by product, application, end user and geography. The global neurological biomarker market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Neurological Biomarker market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global neurological biomarker market segment is segmented on the basis of product, application and end user. Based on product the market is classified as proteomics biomarker, genomics biomarker, metabolomics biomarker, imaging biomarker and others. Based on the application the market is divided into alzheimer's disease, parkinson's disease, schizophrenia, huntington's disease, spinal muscular atrophy and others. The market on the basis of end user is classified as pharmaceutical and biotechnology companies, clinical diagnostics and research organizations.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neurological biomarker market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neurological biomarker market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting neurological biomarker market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neurological biomarker market in these regions.


MARKET PLAYERS
The reports cover key developments in the neurological biomarker market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Neurological Biomarker market are anticipated to lucrative growth opportunities in the future with the rising demand for neurological biomarker market in the global market. Below mentioned is the list of few companies engaged in the neurological biomarker market.

The report also includes the profiles of key neurological biomarker market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Thermo Fisher Scientific Inc
  • Quanterix
  • Banyan Biomarkers, Inc
  • Abbott
  • Myriad RBM
  • Bio-Rad Laboratories, Inc
  • Qiagen
  • Athena Diagnostics
  • Immunarray pvt. Ltd
  • Diagenic Asa
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neurological Biomarkers Market - By Product
1.3.2 Neurological Biomarkers Market - By Application
1.3.3 Neurological Biomarkers Market - By End User
1.3.4 Neurological Biomarkers Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. NEUROLOGICAL BIOMARKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEUROLOGICAL BIOMARKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEUROLOGICAL BIOMARKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROLOGICAL BIOMARKERS - GLOBAL MARKET OVERVIEW
6.2. NEUROLOGICAL BIOMARKERS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NEUROLOGICAL BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PROTEOMICS BIOMARKER
7.3.1. Overview
7.3.2. Proteomics Biomarker Market Forecast and Analysis
7.4. GENOMICS BIOMARKER
7.4.1. Overview
7.4.2. Genomics Biomarker Market Forecast and Analysis
7.5. METABOLOMICS BIOMARKER
7.5.1. Overview
7.5.2. Metabolomics Biomarker Market Forecast and Analysis
7.6. IMAGING BIOMARKER
7.6.1. Overview
7.6.2. Imaging Biomarker Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. NEUROLOGICAL BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ALZHEIMER'S DISEASE
8.3.1. Overview
8.3.2. Alzheimer's Disease Market Forecast and Analysis
8.4. PARKINSON'S DISEASE
8.4.1. Overview
8.4.2. Parkinson's Disease Market Forecast and Analysis
8.5. SCHIZOPHRENIA
8.5.1. Overview
8.5.2. Schizophrenia Market Forecast and Analysis
8.6. HUNTINGTON'S DISEASE
8.6.1. Overview
8.6.2. Huntington's Disease Market Forecast and Analysis
8.7. SPINAL MUSCULAR ATROPHY
8.7.1. Overview
8.7.2. Spinal Muscular Atrophy Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. NEUROLOGICAL BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
9.4. CLINICAL DIAGNOSTICS
9.4.1. Overview
9.4.2. Clinical Diagnostics Market Forecast and Analysis
9.5. RESEARCH ORGANIZATIONS
9.5.1. Overview
9.5.2. Research Organizations Market Forecast and Analysis
10. NEUROLOGICAL BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Neurological Biomarkers Market Overview
10.1.2 North America Neurological Biomarkers Market Forecasts and Analysis
10.1.3 North America Neurological Biomarkers Market Forecasts and Analysis - By Product
10.1.4 North America Neurological Biomarkers Market Forecasts and Analysis - By Application
10.1.5 North America Neurological Biomarkers Market Forecasts and Analysis - By End User
10.1.6 North America Neurological Biomarkers Market Forecasts and Analysis - By Countries
10.1.6.1 United States Neurological Biomarkers Market
10.1.6.1.1 United States Neurological Biomarkers Market by Product
10.1.6.1.2 United States Neurological Biomarkers Market by Application
10.1.6.1.3 United States Neurological Biomarkers Market by End User
10.1.6.2 Canada Neurological Biomarkers Market
10.1.6.2.1 Canada Neurological Biomarkers Market by Product
10.1.6.2.2 Canada Neurological Biomarkers Market by Application
10.1.6.2.3 Canada Neurological Biomarkers Market by End User
10.1.6.3 Mexico Neurological Biomarkers Market
10.1.6.3.1 Mexico Neurological Biomarkers Market by Product
10.1.6.3.2 Mexico Neurological Biomarkers Market by Application
10.1.6.3.3 Mexico Neurological Biomarkers Market by End User
10.2. EUROPE
10.2.1 Europe Neurological Biomarkers Market Overview
10.2.2 Europe Neurological Biomarkers Market Forecasts and Analysis
10.2.3 Europe Neurological Biomarkers Market Forecasts and Analysis - By Product
10.2.4 Europe Neurological Biomarkers Market Forecasts and Analysis - By Application
10.2.5 Europe Neurological Biomarkers Market Forecasts and Analysis - By End User
10.2.6 Europe Neurological Biomarkers Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Neurological Biomarkers Market
10.2.6.1.1 Germany Neurological Biomarkers Market by Product
10.2.6.1.2 Germany Neurological Biomarkers Market by Application
10.2.6.1.3 Germany Neurological Biomarkers Market by End User
10.2.6.2 France Neurological Biomarkers Market
10.2.6.2.1 France Neurological Biomarkers Market by Product
10.2.6.2.2 France Neurological Biomarkers Market by Application
10.2.6.2.3 France Neurological Biomarkers Market by End User
10.2.6.3 Italy Neurological Biomarkers Market
10.2.6.3.1 Italy Neurological Biomarkers Market by Product
10.2.6.3.2 Italy Neurological Biomarkers Market by Application
10.2.6.3.3 Italy Neurological Biomarkers Market by End User
10.2.6.4 Spain Neurological Biomarkers Market
10.2.6.4.1 Spain Neurological Biomarkers Market by Product
10.2.6.4.2 Spain Neurological Biomarkers Market by Application
10.2.6.4.3 Spain Neurological Biomarkers Market by End User
10.2.6.5 United Kingdom Neurological Biomarkers Market
10.2.6.5.1 United Kingdom Neurological Biomarkers Market by Product
10.2.6.5.2 United Kingdom Neurological Biomarkers Market by Application
10.2.6.5.3 United Kingdom Neurological Biomarkers Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Neurological Biomarkers Market Overview
10.3.2 Asia-Pacific Neurological Biomarkers Market Forecasts and Analysis
10.3.3 Asia-Pacific Neurological Biomarkers Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Neurological Biomarkers Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Neurological Biomarkers Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Neurological Biomarkers Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Neurological Biomarkers Market
10.3.6.1.1 Australia Neurological Biomarkers Market by Product
10.3.6.1.2 Australia Neurological Biomarkers Market by Application
10.3.6.1.3 Australia Neurological Biomarkers Market by End User
10.3.6.2 China Neurological Biomarkers Market
10.3.6.2.1 China Neurological Biomarkers Market by Product
10.3.6.2.2 China Neurological Biomarkers Market by Application
10.3.6.2.3 China Neurological Biomarkers Market by End User
10.3.6.3 India Neurological Biomarkers Market
10.3.6.3.1 India Neurological Biomarkers Market by Product
10.3.6.3.2 India Neurological Biomarkers Market by Application
10.3.6.3.3 India Neurological Biomarkers Market by End User
10.3.6.4 Japan Neurological Biomarkers Market
10.3.6.4.1 Japan Neurological Biomarkers Market by Product
10.3.6.4.2 Japan Neurological Biomarkers Market by Application
10.3.6.4.3 Japan Neurological Biomarkers Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Neurological Biomarkers Market Overview
10.4.2 Middle East and Africa Neurological Biomarkers Market Forecasts and Analysis
10.4.3 Middle East and Africa Neurological Biomarkers Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Neurological Biomarkers Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Neurological Biomarkers Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Neurological Biomarkers Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Neurological Biomarkers Market
10.4.6.1.1 South Africa Neurological Biomarkers Market by Product
10.4.6.1.2 South Africa Neurological Biomarkers Market by Application
10.4.6.1.3 South Africa Neurological Biomarkers Market by End User
10.4.6.2 Saudi Arabia Neurological Biomarkers Market
10.4.6.2.1 Saudi Arabia Neurological Biomarkers Market by Product
10.4.6.2.2 Saudi Arabia Neurological Biomarkers Market by Application
10.4.6.2.3 Saudi Arabia Neurological Biomarkers Market by End User
10.4.6.3 U.A.E Neurological Biomarkers Market
10.4.6.3.1 U.A.E Neurological Biomarkers Market by Product
10.4.6.3.2 U.A.E Neurological Biomarkers Market by Application
10.4.6.3.3 U.A.E Neurological Biomarkers Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Neurological Biomarkers Market Overview
10.5.2 South and Central America Neurological Biomarkers Market Forecasts and Analysis
10.5.3 South and Central America Neurological Biomarkers Market Forecasts and Analysis - By Product
10.5.4 South and Central America Neurological Biomarkers Market Forecasts and Analysis - By Application
10.5.5 South and Central America Neurological Biomarkers Market Forecasts and Analysis - By End User
10.5.6 South and Central America Neurological Biomarkers Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Neurological Biomarkers Market
10.5.6.1.1 Brazil Neurological Biomarkers Market by Product
10.5.6.1.2 Brazil Neurological Biomarkers Market by Application
10.5.6.1.3 Brazil Neurological Biomarkers Market by End User
10.5.6.2 Argentina Neurological Biomarkers Market
10.5.6.2.1 Argentina Neurological Biomarkers Market by Product
10.5.6.2.2 Argentina Neurological Biomarkers Market by Application
10.5.6.2.3 Argentina Neurological Biomarkers Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NEUROLOGICAL BIOMARKERS MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. QUANTERIX
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BANYAN BIOMARKERS, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBOTT
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MYRIAD RBM
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIO-RAD LABORATORIES, INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. QIAGEN
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ATHENA DIAGNOSTICS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. IMMUNARRAY PVT. LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DIAGENIC ASA.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Thermo Fisher Scientific Inc
2. Quanterix
3. Banyan Biomarkers, Inc
4. Abbott
5. Myriad RBM
6. Bio-Rad Laboratories, Inc
7. Qiagen
8. Athena Diagnostics
9. Immunarray pvt. Ltd
10. Diagenic Asa